Prevalence of current tobacco use, females in Upper middle income
Upper middle income: Prevalence of current tobacco use, females was 3.9% in 2024. ▼ Falling
Prevalence of current tobacco use, females in Upper middle income, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of female adults.
Analysis
Upper middle income recorded 3.9% for prevalence of current tobacco use, females in 2024. That is the lowest value across all 9 years on record.
Compared with earlier readings it is down 1.8% on the previous year and down 18.9% over ten years.
Over the whole period, prevalence of current tobacco use, females in Upper middle income peaked at 7.4% in 2000 and was at its lowest, 3.9%, in 2024.
Upper middle income ranks 31st of 46 groups on this measure, in the middle of the range.
Prevalence of current tobacco use, females in Upper middle income, year by year
| Year | % of female adults | Change |
|---|---|---|
| 2000 | 7.4% | — |
| 2005 | 6.2% | -15.4% |
| 2007 | 5.9% | -5.2% |
| 2010 | 5.4% | -8.6% |
| 2015 | 4.8% | -11.4% |
| 2020 | 4.3% | -11.1% |
| 2022 | 4.1% | -4.6% |
| 2023 | 3.9% | -2.7% |
| 2024 | 3.9% | -1.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.5% | 5.9% | 7.4% | 3 |
| 2010s | 5.1% | 4.8% | 5.4% | 2 |
| 2020s | 4.0% | 3.9% | 4.3% | 4 |
Countries ranked near Upper middle income
More health data for Upper middle income
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 1.94 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0359 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.71 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0413 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 2.11 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0394 units per person (2025)
- Population ages 30-34, female, annual growth rate -3.39 % change on previous year (2025)
Frequently asked questions
- What is prevalence of current tobacco use, females in Upper middle income?
- Prevalence of current tobacco use, females in Upper middle income was 3.9% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use, females recorded in Upper middle income?
- The highest recorded value was 7.4% in 2000.
- What is the lowest prevalence of current tobacco use, females recorded in Upper middle income?
- The lowest recorded value was 3.9% in 2024.
- How does Upper middle income rank for prevalence of current tobacco use, females?
- Upper middle income ranks 31st out of 46 groups with data for 2024.
- Is prevalence of current tobacco use, females rising or falling in Upper middle income?
- Over the last ten years it is down 18.9%. The long-run trend across the full record is falling.
- Where does this Upper middle income data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use, females (% of female adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the female population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.